317. HETEROGENEITY OF CYTOKINE EXPRESSION IN ACTIVE SYSTEMIC LUPUS ERYTHEMATOSUS
John A. Reynolds(Manchester Academic Health Science Centre), Ian N Bruce(University of Manchester), Eileen Holling Lee(Aeirtec (United Kingdom)), Ben Parker(Manchester Royal Infirmary), S. Kilfeather(Aeirtec (United Kingdom)), Eoghan McCarthy(Manchester Academic Health Science Centre), Jamie C. Sergeant(Manchester Academic Health Science Centre), Sahena Haque(Wythenshawe Hospital), Elaine Lee(Maine Farmland Trust)
Cited by 0
Related Papers
Prediction models for diagnosis and prognosis of covid-19: systematic review and critical appraisal
|BMJ|2020|3.3k
Frequency and Distribution of Chest Radiographic Findings in Patients Positive for COVID-19
|Radiology|2020|1.5k
Trial of Anifrolumab in Active Systemic Lupus Erythematosus
|New England Journal of Medicine|2019|1.3k
EULAR recommendations for the management of systemic lupus erythematosus: 2023 update
|Annals of the Rheumatic Diseases|2023|913
Treat-to-target in systemic lupus erythematosus: recommendations from an international task force
|Annals of the Rheumatic Diseases|2014|726